Jes Dietrich

Awards Nomination 20+ Million Readerbase

PMC/PubMed Indexed Articles

Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation

MEFA (multiepitope fusion antigen)-Novel Technology for Structural Vaccinology, Proof from Computational and Empirical Immunogenicity Characterization of an Enterotoxigenic Escherichia coli (ETEC) Adhesin MEFA

Google Scholar citation report

Citations : 2051

Journal of Vaccines & Vaccination received 2051 citations as per Google Scholar report

Journal of Vaccines & Vaccination peer review process verified at publons

25+ Million Website Visitors

Indexed In

Academic Journals Database
Open J Gate
Genamics JournalSeek
JournalTOCs
China National Knowledge Infrastructure (CNKI)
Scimago
Ulrich's Periodicals Directory
RefSeek
Hamdard University
EBSCO A-Z
OCLC- WorldCat
Publons
MIAR
University Grants Commission
Geneva Foundation for Medical Education and Research
Euro Pub
Google Scholar

Useful Links

Share This Page

Tweets by Vaccine41931315

Open Access Journals

Jes Dietrich

Department of Infectious Disease Immunology, Statens Serum Institut, Denmark

Biography

Jes Dietrich is currently working as a Project Manager in Vaccine development and antigen discovery. He have so far been involved in leading two tuberculosis vaccine candidates into clinical trials and have recently received 250 million DKr from Gates foundation to take a new enhanced Polio vaccine into a phase 3 clinical trial in 2016/17 (I am Principle Investigator on that project). Currently he working as a Project Manager in infection and Immunology.manage projects aimed at understanding the interaction between infectious agents, such as Chlamydia, M.tb, Streptococcus Pyogenes and Polio virus, and the immune system.